Episode Details

Back to Episodes
Pharmaceutical Executive Daily: FDA Grants Ultomiris Accelerated Approval in the U.S.

Pharmaceutical Executive Daily: FDA Grants Ultomiris Accelerated Approval in the U.S.

Published 3 weeks, 6 days ago
Description
FDA grants Ultomiris accelerated approval for primary immunoglobulin A nephropathy, a pharma funding roundup covers Alcon’s $550 million acquisition of Neurotech and AI Proteins’ collaboration with Astellas, and Incubate’s John Stanford on which therapeutic areas MFN deals might hit hardest.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us